🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Phase 2 Study of Abbreviated 3 Cycles of Rituximab plus CHOP (Cyclophospham...
Status
Unknown
Location
Multiple Locations
Start Date
2016-12-07
Trial ID
NCT03399747
Treatments Being Tested
a prospective, multicenter, randomized, open-label, Phase II, two arms inte...
Status
Unknown
Location
Multiple Locations
Start Date
2016-05
Trial ID
NCT02757196
Treatments Being Tested
This study will test if adding ruxolitinib to standard multi-drug chemother...
Status
Recruiting
Location
University of Chicago Medical Center
Start Date
2019-05-28
Trial ID
NCT03571321
This trial aims to demonstrate the feasibility of this approach to reliably...
Status
Recruiting
Location
AHN Cancer Institute - West Penn Hospital
Start Date
2022-04-19
Trial ID
NCT05281809
Treatments Being Tested
The goal of this clinical research study is to find the highest tolerable d...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2011-08
Trial ID
NCT01421173
The purpose of this study is to determine whether rituximab as an adjuvant ...
Status
Terminated
Location
General Hospital Vienna, Dep. of Dermatology, Division of Immunology and Infectious Diseases
Start Date
2007-10
Trial ID
NCT01032122
Treatments Being Tested
Phase II clinical trial to assess the efficacy of donor regulatory enriched...
Status
Unknown
Location
José Antonio Pérez Simón
Start Date
2022-03-24
Trial ID
NCT05095649
Treatments Being Tested
This is a two-center proof-of-concept study, ancillary to the MetACTIV stud...
Status
Completed
Location
Centre Hospitalier Universitaire
Start Date
2022-06-27
Trial ID
NCT05329337
Treatments Being Tested
Kidney transplantation is the best treatment for chronic renal failure in t...
Status
Unknown
Location
Multiple Locations
Start Date
2023-05-01
Trial ID
NCT05785936
Treatments Being Tested
A. Four groups of patients with type 2 diabetes mellitus with high or very ...
Status
Recruiting
Location
"Attikon" University General Hospital
Start Date
2017-11-03
Trial ID
NCT03878706